Japanese green tea as a cancer preventive in humans
Japanese green tea as a cancer preventive in humans
复制标题
DOI:
10.1111/j.1753-4887.1996.tb03821.x
复制
发表时间:
1996-11-01
影响因子:
6.1
通讯作者:
Sakai, Y
中科院分区:
文献类型:
--
作者:
Fujiki, H;Suganuma, M;Sakai, Y
Drinking green tea today is part of Japanese culture. The tea plant Camellia sinensis was imported by a Japanese Zen priest in the 12th century from China to Japan as a medicine. However, as a medicine, tea was not much studied. At present we drink tea during and after meals, that is, throughout the day. One cup of green tea infusion contains about 100-200 mg of tannins, the main constituent of which is (-)-epigallocatechin gallate (EGCG). Thus, EGCG is one of the tea polyphenols or tea tannins.In 1983 we did the first scientific examination of EGCG as a cancer-preventive material in collaboration with Takuo Okuda, who was a professor of pharmacology at Okayama University at that time. We began with a study of the anticarcinogenic effects of polyphenols derived from medicinal plants and drugs. 1, 2 We first examined whether a polyphenol shared the phorbol ester receptor with a tumor promoter, 1 2-O-tetradecanoylphorbol-13-acetate (TPA). 3 Experimentally, EGCG inhibited in a dose-dependent manner the specific^ sup 3^ H-TPA binding to the phorbol ester receptor in a membrane fraction of mouse skin. The median effective dose (ED^ sub 50^) of EGCG for inhibition was about 300 times less than that of TPA. Moreover, penta-O-galloyl-betaD-glucose isolated from a gall, Shisandrea fructus, pedunculagin, chebulinic acid, and buddledin A bound to the same receptors with similar ED^ sub 50^ values as EGCG did, although their structures are related neither to that of TPA nor to each other. 1 These results raised a question: Does EGCG act as an antagonist, inhibiting the action of TPA, or as an agonist, activating protein kinase C as TPA does?